Abstract

Abstract
This article compares the effectiveness of the PET/CT scan and bone scintigraphy for the detection of bone metastases in patients with breast cancer. Background Positron emission tomography/computed tomography (PET/CT) has become in recent years a tool for breast cancer (BC) staging. However, its accuracy to detect bone metastases is classically considered inferior to bone scintigraphy (BS). The purpose of this work is to compare the effectiveness of bone metastases detection between PET/CT and BS. Materials and Methods Prospective study of 410 female patients treated in a Comprehensive Cancer Center between 2014 and 2020 that performed PET/CT and BS for staging purposes. The image analysis was performed by 2 senior nuclear medicine physicians. The comparison was performed based on accuracy, sensitivity, and specificity on a patient and anatomical region level and was assessed using McNemar's Test. An average ROC was calculated for the anatomical region analysis. Results PET/CT presented higher values of accuracy and sensitivity (98.0% and 93.83%), surpassing BS (95.61% and 81.48%) in detecting bone disease. There was a significant difference in favor of PET/CT (sensitivity 93.83% vs. 81.48%), however, there is no significant difference in eliminating false positives (specificity 99.09% vs. 99.09%). PET/CT presented the highest accuracy and sensitivity values for most of the bone segments, only surpassed by BS for the cranium. There was a significant difference in favor of PET/CT in the upper limb, spine, thorax (sternum) and lower limb (pelvis and sacrum), and in favor of BS in the cranium. The ROC showed that PET/CT has a higher sensitivity and consistency across the bone segments. Conclusion With the correct imaging protocol, PET/CT does not require BS for patients with BC staging.

Abstract
Since its emergence in the 1960s, Artificial Intelligence (AI) has grown to conquer many technology products and their fields of application. Machine learning, as a major part of the current AI solutions, can learn from the data and through experience to reach high performance on various tasks. This growing success of AI algorithms has led to a need for interpretability to understand opaque models such as deep neural networks. Various requirements have been raised from different domains, together with numerous tools to debug, justify outcomes, and establish the safety, fairness and reliability of the models. This variety of tasks has led to inconsistencies in the terminology with, for instance, terms such as interpretable, explainable and transparent being often used interchangeably in methodology papers. These words, however, convey different meanings and are weighted differently across domains, for example in the technical and social sciences. In this paper, we propose an overarching terminology of interpretability of AI systems that can be referred to by the technical developers as much as by the social sciences community to pursue clarity and efficiency in the definition of regulations for ethical and reliable AI development. We show how our taxonomy and definition of interpretable AI differ from the ones in previous research and how they apply with high versatility to several domains and use cases, proposing a-highly needed-standard for the communication among interdisciplinary areas of AI.

Abstract

Abstract

Abstract
The machine learning field has grown considerably in the last years. There are, however, some problems still to be solved. The characteristics of the training sets, for instance, are known to affect the classifiers performance. Here, and inspired by medical applications, we are interested in studying datasets that are both ordinal and imbalanced. Ordinal datasets present labels where only the relative ordering between different values is significant. Imbalanced datasets have very different quantity of examples per class. Building upon our previous work, we make three new contributions, (1) extend the number of classifiers, (2) evaluate two techniques to balance intermediate train sets in binary decomposition methods (often used in multi-class contexts and ordinal ones in particular), and (3) propose a new, iterative, classifier-based oversampling algorithm that we name InCuBAtE. Experiments were made on 6 private datasets, concerning the assessment of response to treatment on oncologic diseases, and 15 public datasets widely used in the literature. When compared with our previous work, results have improved (or remained the same) for 4 of the 6 private datasets and for 11 out of the 15 public datasets.